1
![Invo Bioscience]()
![Invo Bioscience]()
![Invo Bioscience]()
Invo Bioscience
Leadership team
Claude Ranoux (Founder)
Products/ Services
Biotechnology, Health Care, Medical Device
Number of Employees
0 - 50
Headquarters
Medford, Massachusetts, United States
Established
2008
Company Registration
SEC CIK number: 0001417926
Traded as
NASDAQ:IVOB
Overview
Location
Summary
Invo Bioscience, Inc. is a medical technology company focused on revolutionizing the treatment of female infertility with the INVO Procedure, a breakthrough in-vivo Intra-Cytoplasmic Sperm Injection (ICSi) procedure
History
Invo Bioscience was founded in 2012 to address the unmet need of making in-vivo Intra-Cytoplasmic Sperm Injection (ICSI) more accessible and affordable, while preserving the natural process of in-vitro fertilization. The INVO Procedure represents a major breakthrough in both cost and access to in-vivo Intra-Cytoplasmic Sperm Injection (ICSI).
Mission
Our mission is to provide innovative, costeffective and patient-centric solutions that improve healthcare and fertility outcomes for couples worldwide.
Vision
Our vision is to create a world in which all patients have access to high quality healthcare and a fulfilling family life.
Key Team
Claude Ranoux (Founder)
Recognition and Awards
Invo Bioscience has been the recipient of numerous awards, including the 2017 Tibbetts Award, the 2018 Fertility Rising Award, the 2019 US Small Business Innovation Research award, and the 2020 Wearable Technologies Innovation award.
References
Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.
Leadership team
Claude Ranoux (Founder)
Products/ Services
Biotechnology, Health Care, Medical Device
Number of Employees
0 - 50
Headquarters
Medford, Massachusetts, United States
Established
2008
Company Registration
SEC CIK number: 0001417926
Traded as
NASDAQ:IVOB